Literature DB >> 29277725

A hybrid approach to predict the relationship between tablet tensile strength and compaction pressure using analytical powder compression.

Ann-Sofie Persson1, Göran Alderborn2.   

Abstract

The objective was to present a hybrid approach to predict the strength-pressure relationship (SPR) of tablets using common compression parameters and a single measurement of tablet tensile strength. Experimental SPR were derived for six pharmaceutical powders with brittle and ductile properties and compared to predicted SPR based on a three-stage approach. The prediction was based on the Kawakita b-1 parameter and the in-die Heckel yield stress, an estimate of maximal tensile strength, and a parameter proportionality factor α. Three values of α were used to investigate the influence of the parameter on the SPR. The experimental SPR could satisfactorily be described by the three stage model, however for sodium bicarbonate the tensile strength plateau could not be observed experimentally. The shape of the predicted SPR was to a minor extent influenced by the Kawakita b-1 but the width of the linear region was highly influenced by α. An increased α increased the width of the linear region and thus also the maximal predicted tablet tensile strength. Furthermore, the correspondence between experimental and predicted SPR was influenced by the α value and satisfactory predictions were in general obtained for α = 4.1 indicating the predictive potential of the hybrid approach.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Compaction; Compression; Prediction; Tablet tensile strength; Yield pressure

Mesh:

Substances:

Year:  2017        PMID: 29277725     DOI: 10.1016/j.ejpb.2017.12.011

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  1 in total

1.  Atypical compaction behaviour of disordered lactose explained by a shift in type of compact fracture pattern.

Authors:  Samaneh Pazesh; Ann-Sofie Persson; Göran Alderborn
Journal:  Int J Pharm X       Date:  2019-11-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.